dazmegrel has been researched along with bw-755c in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aramburo, MJ; Choi, JH; Hammerman, C | 1 |
Aramburo, MJ; Hammerman, C; Hill, V | 1 |
2 other study(ies) available for dazmegrel and bw-755c
Article | Year |
---|---|
Prostanoid inhibition and group B hemolytic streptococci (GBS) induced neutropenia in newborn piglets.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Animals; Animals, Newborn; Blood Pressure; Cyclooxygenase Inhibitors; Hypertension, Pulmonary; Imidazoles; Leukocyte Count; Lipoxygenase Inhibitors; Neutropenia; Neutrophils; Pulmonary Artery; Streptococcus agalactiae; Swine; Thromboxane B2; Vasoconstriction | 1990 |
Lipoxygenase and cyclooxygenase blockade by BW755C does not prevent the secondary phase of septic pulmonary hypertension.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cyclooxygenase Inhibitors; Heart Rate; Hemodynamics; Hypertension, Pulmonary; Imidazoles; Lipoxygenase Inhibitors; Pyrazoles; Swine; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1989 |